{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:00:35Z","timestamp":1783792835276,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00296-021-04929-w","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T13:02:25Z","timestamp":1624712545000},"page":"1625-1631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7508-8324","authenticated-orcid":false,"given":"Lamia.","family":"Oulkadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-2423","authenticated-orcid":false,"given":"Samira.","family":"Rostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-5034","authenticated-orcid":false,"given":"Ihsane.","family":"Hmamouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-6133","authenticated-orcid":false,"given":"Salma.","family":"El Hassani Sbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-0824","authenticated-orcid":false,"given":"Imane.","family":"El Binoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-4332","authenticated-orcid":false,"given":"Bouchra.","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-4341","authenticated-orcid":false,"given":"Redouane.","family":"Abouqal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-2142","authenticated-orcid":false,"given":"Fadoua.","family":"Allali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-1368","authenticated-orcid":false,"given":"Lahsen.","family":"Achemlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-3407","authenticated-orcid":false,"given":"Imane.","family":"El Bouchti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0668-5680","authenticated-orcid":false,"given":"Abdellah.","family":"El Maghraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-4173","authenticated-orcid":false,"given":"Imad.","family":"Ghozlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4190-1481","authenticated-orcid":false,"given":"Hasna.","family":"Hassikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6275-4391","authenticated-orcid":false,"given":"Taoufik.","family":"Harzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-5594","authenticated-orcid":false,"given":"Linda.","family":"Ichchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-8479","authenticated-orcid":false,"given":"Ouafae.","family":"Mkinsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-2532","authenticated-orcid":false,"given":"Redouane.","family":"Niamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-1750","authenticated-orcid":false,"given":"Rachid.","family":"Bahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"4929_CR1","unstructured":"World Health Organization (2019) Global tuberculosis report 2019. Available at: www.who.int"},{"key":"4929_CR2","volume-title":"Latent tuberculosis infection\u2014updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) Latent tuberculosis infection\u2014updated and consolidated guidelines for programmatic management. WHO, Switzerland"},{"key":"4929_CR3","unstructured":"World Health Organization (2018) Global tuberculosis report 2018. Available from: www.who.int"},{"issue":"5","key":"4929_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1183\/09031936.00120908","volume":"33","author":"U Mack","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D et al (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33(5):956\u2013973","journal-title":"Eur Respir J"},{"issue":"12","key":"4929_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2169\/internalmedicine.53.1936","volume":"53","author":"T Ishiguro","year":"2014","unstructured":"Ishiguro T, Takayanagi N, Kagiyama N, Yanagisawa T, Sugita Y (2014) Characteristics of tuberculosis in patients with rheumatoid arthritis: a retrospective single-center study. Intern Med 53(12):1291\u20131298. https:\/\/doi.org\/10.2169\/internalmedicine.53.1936","journal-title":"Intern Med"},{"issue":"3","key":"4929_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","volume":"78","author":"L Baronnet","year":"2011","unstructured":"Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez CST, Schaeverbeke T (2011) Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78(3):279\u2013284. https:\/\/doi.org\/10.1016\/j.jbspin.2010.12.004","journal-title":"Joint Bone Spine"},{"key":"4929_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/BTT.S59574","volume":"8","author":"KM Alawneh","year":"2014","unstructured":"Alawneh KM, Ayesh MH, Khassawneh BY, Saadeh SS, Smadi M, Bashaireh K (2014) Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis. Biologics 8:193\u2013198. https:\/\/doi.org\/10.2147\/BTT.S59574","journal-title":"Biologics"},{"issue":"6","key":"4929_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/14787210.2018.1483238","volume":"16","author":"D Goletti","year":"2018","unstructured":"Goletti D, Petrone L, Ippolito G, Niccoli L, Nannini C, Cantini F (2018) Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Expert Reviw Anti Infect Ther 16(6):501\u2013512. https:\/\/doi.org\/10.1080\/14787210.2018.1483238","journal-title":"Expert Reviw Anti Infect Ther"},{"issue":"8","key":"4929_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.rmr.2018.08.007","volume":"35","author":"E Bergot","year":"2018","unstructured":"Bergot E, Abiteboul D, Andr\u00e9jak C, Antoun F et al (2018) Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis. Revue des Mal Respir 35(8):852\u2013858","journal-title":"Revue des Mal Respir"},{"key":"4929_CR10","first-page":"32","volume":"49","author":"I Hmamouchi","year":"2019","unstructured":"Hmamouchi I, Abouqal R, AchemlalAllaliBahiri LFR et al (2019) The Moroccan registry of biological therapies in rheumatic diseases (RBSMR): methods and preliminaries results. Rev Mar Rhum 49:32\u201337","journal-title":"Rev Mar Rhum"},{"key":"4929_CR11","unstructured":"Manuel de r\u00e9f\u00e9rence du syst\u00e8me d'information sanitaire du programme national de lutte antituberculeuse, direction de l\u2019\u00e9pid\u00e9miologie et de lutte contre les maladies 2016. Available at www.sante.gov.ma"},{"key":"4929_CR12","unstructured":"WHO (1963) The WHO standard tuberculin test [cited 1 June 2018]. Available from: http:\/\/apps.who.int\/iris\/handle\/10665\/112241"},{"key":"4929_CR13","unstructured":"(2008) Rev. Mal. Respir. L'intradermo-r\u00e9action \u00e0 la tuberculine (IDR) ou test \u00e0 la tuberculine. 20(6\u2013C2):7S27"},{"issue":"8","key":"4929_CR14","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s10067-017-3714-6","volume":"36","author":"G Garziera","year":"2017","unstructured":"Garziera G, Morsch AL, Otesbelgue F et al (2017) Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents. Clin Rheumatol 36(8):1891\u20131896. https:\/\/doi.org\/10.1007\/s10067-017-3714-6","journal-title":"Clin Rheumatol"},{"key":"4929_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"LD de Ponce","year":"2005","unstructured":"de Ponce LD, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum dis 64:1360\u20131361","journal-title":"Ann Rheum dis"},{"key":"4929_CR16","doi-asserted-by":"publisher","first-page":"430134","DOI":"10.1155\/2014\/430134","volume":"2014","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Das SK, Agarwal GG, Srivastava R (2014) Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti-TNF therapies. Interdiscip Perspect Infect Dis 2014:430134","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"4929_CR17","first-page":"54","volume":"25","author":"IH Koker","year":"2007","unstructured":"Koker IH, Pamuk ON, Karlikaya C, Tuncbilek N, Cakir N (2007) A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 25:54\u201359","journal-title":"Clin Exp Rheumatol"},{"key":"4929_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.11604\/pamj.2021.38.183.27081","volume":"38","author":"M Eddaoudi","year":"2021","unstructured":"Eddaoudi M, Rostom S, Hmamouchi I, El Binoune I, Amine B et al (2021) The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies. Pan Afr Med 38:183. https:\/\/doi.org\/10.11604\/pamj.2021.38.183.27081","journal-title":"Pan Afr Med"},{"key":"4929_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3899\/jrheum.140103","volume":"91","author":"F Cantini","year":"2014","unstructured":"Cantini F, Niccoli L, Goletti D (2014) Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-\u03b1 (TNF-\u03b1) targeted biologics and recently licensed TNF-\u03b1 inhibitors: data from clinical trials and national registries. J Rheumatol Suppl 91:56\u201364","journal-title":"J Rheumatol Suppl"},{"issue":"7","key":"4929_CR20","doi-asserted-by":"publisher","first-page":"e0198756","DOI":"10.1371\/journal.pone.0198756","volume":"13","author":"DH Jeong","year":"2018","unstructured":"Jeong DH, Kang J, Jung YJ, Yoo B, Lee C-K, Kim Y-G et al (2018) Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA. PLoS ONE 13(7):e0198756. https:\/\/doi.org\/10.1371\/journal.pone.0198756","journal-title":"PLoS ONE"},{"issue":"8","key":"4929_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/1756-185X.13261","volume":"21","author":"AN Malaviya","year":"2018","unstructured":"Malaviya AN, Aggarwal VK, Rawat R, Baghel S, Thakran R, Zaheer Q, Garg S, Kapoor S (2018) Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country: the importance of Mantoux and Quantiferon-TB Gold tests. Int J Rheum Dis 21(8):1563\u20131571. https:\/\/doi.org\/10.1111\/1756-185X.13261","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"4929_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64(5):625\u2013639. https:\/\/doi.org\/10.1002\/acr.21641","journal-title":"Arthritis Care Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04929-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T10:09:30Z","timestamp":1627380570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04929-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04929-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"15 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}